MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $18,731,000 | -32.2% | 109,345 | -13.1% | 0.01% | -41.7% |
| Q4 2020 | $27,643,000 | -43.4% | 125,858 | -57.2% | 0.02% | -52.9% |
| Q3 2020 | $48,814,000 | +17.3% | 293,970 | -19.4% | 0.05% | +4.1% |
| Q2 2020 | $41,626,000 | +74.7% | 364,599 | +17.6% | 0.05% | +16.7% |
| Q1 2020 | $23,833,000 | -21.0% | 310,040 | +32.4% | 0.04% | +20.0% |
| Q4 2019 | $30,174,000 | +165.3% | 234,163 | -12.7% | 0.04% | +250.0% |
| Q4 2018 | $11,373,000 | +30.4% | 268,100 | +44.8% | 0.01% | -9.1% |
| Q3 2018 | $8,723,000 | – | 185,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |